Navigation Links
InterMune Reports Third Quarter 2010 Financial Results
Date:10/28/2010

third quarter of 2010, compared with $9.9 million in the same period a year earlier, an increase of 10 percent.  G&A expenses were $38.7 million in the first nine months of 2010, an increase of 44 percent from $26.9 million in 2009.  The higher G&A expenses are primarily attributed to costs related to preparation for the potential U.S. commercialization of pirfenidone in 2010, which did not occur.  

The net loss for the third quarter of 2010 was $24.3 million, or $0.44 per share, compared with a net loss of $8.8 million, or $0.19 per share, in the third quarter of 2009.  Net loss for the first nine months of 2010 was $83.7 million, or $1.55 per share, compared with a net loss of $87.4 million, or $2.00 per share, in the comparable period of 2009.As of September 30, 2010, InterMune had cash, cash equivalents and available-for-sale securities of approximately $133.5 million, which does not include net proceeds of $175.0 million from the company's sale to Roche of worldwide development and commercialization rights for danoprevir, announced on October 6, 2010.

Guidance for 2010 Expenses  The company today provided updated financial guidance from that initially provided on July 27, 2010, for operating expenses in 2010.

Operating Expenses

  • R&D expense:  anticipated to be between $65 and $70 million, compared to the company's previous guidance of between $80 and $90 million.
  • G&A expense:  anticipated to be between $45 and $50 million, compared to the company's previous guidance of between $40 and $50 million.  

  • Revenue: InterMune is not providing full-year 2010 revenue guidance for the company at this time as the final determination has not yet been made regarding the accounting treatment for the transaction in which InterMune sold worldwide development and commercialization rights for danoprevir to Roche on October 6, 2010.Conference
    '/>"/>

    SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
    2. InterMune to Release Second Quarter Financial Results on July 27
    3. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
    4. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
    5. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
    6. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
    7. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
    8. InterMune to Present at Deutsche Bank Biotech Confab
    9. InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
    10. InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
    11. InterMune to Present at JMP Securities Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015  A new analysis of ... D 2015 enrollment data shows that 81 percent of ... access and extra discounts at certain pharmacies. The findings ... "Preferred pharmacy plans are now the foundation of Medicare ...
    (Date:1/23/2015)... and DUBLIN , Jan. 23, ... agreement with KRS Global Biotechnology, Inc. for the compounding, packaging ... compounded for shipment in the United States ... approved Outsourcing Facility capable of compounding naltrexone tablets in various ...
    (Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
    Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
    ... Jan. 10, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Investor Day on January 21, 2011 in New York City. ... Time and will be simultaneously webcast. At ... for 2011. The presenters will include: Paul Bisaro, Watson,s President ...
    ... Inc., a privately held, medical device company, today announced ... Annual Healthcare Conference to be held January 10 -13, ... Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20090409/SF96872LOGO ) ... Wyles, President and CEO, will provide a corporate overview, ...
    Cached Medicine Technology:
    (Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
    (Date:1/22/2015)... Plainsboro, NJ (PRWEB) January 22, 2015 ... advocate and keynote speaker at the upcoming 32nd ... by ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , ... breast would have gone undetected if she had not ...
    (Date:1/22/2015)... 2015 IsoComforter, Inc. has introduced the most ... IsoTube design to treat specific body parts and muscle groups. ... and easy to use patented cold therapy machine with the ... orthopedic and muscle injuries. IsoComforter has become the industry ...
    (Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
    (Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
    Breaking Medicine News(10 mins):Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Wicked Plants are taking over the Science Museum of Virginia 2
    ... Purafilter2000 was named the top selling air filter in ... running by The Nielsen Company. Purafilter2000 says its ... distribution approach has led to its current 42.6% market ... stores, making it number one. Beyond that, Purafilter2000 ...
    ... DALLAS and SAN ANTONIO, March 26 /PRNewswire-HISPANIC PR ... its Promotores Initiative, launched,three years ago in partnership ... help the uninsured in San Antonio and Corpus ... Through the Initiative, Pfizer,will train five community health ...
    ... Hospital in Houston has agreed to pay the ... it defrauded the federal Medicare program, the Justice ... improperly increased charges to Medicare patients in order ... addition to its standard payment system, Medicare pays ...
    ... TyrellSpecial Performance by Dancing With The Stars Professional ... Bonnie Hunt will receive the "True Grit" ... Rosen will receive "The Duke" Award ... annual Odyssey Ball. The yearly fundraising event ...
    ... Williams Named National Epilepsy Spokespersons WASHINGTON, March 26 ... Hutto, TX will travel to Washington, D.C., Sunday, March ... congressional leaders and gain their support for epilepsy public ... epilepsy as part of the seventh annual Kids Speak ...
    ... chronic obstructive pulmonary disease, study finds , , THURSDAY, ... pattern may explain why people with moderate to ... increased risk for aspiration pneumonia, researchers report. , ... between normal breathing and swallowing patterns (during eating) ...
    Cached Medicine News:Health News:Innovative Distribution Makes Purafilter2000 #1 for Consumers and Food & Drug Stores 2Health News:March 22-28 is Cover the Uninsured Week 2Health News:March 22-28 is Cover the Uninsured Week 3Health News:Houston's Methodist Hospital to Pay U.S. More Than $9 Million to Resolve Allegations of Overcharging Medicare 2Health News:John Wayne Cancer Institute Auxiliary Honors Award-Winning Actress Bonnie Hunt and Philanthropists Donna & Harvey Rosen at the 24th Annual Odyssey Ball 2Health News:Texas Siblings Share Epilepsy Message on Capitol Hill 2Health News:Swallowing-Breathing Dysfunction Worsens Lung Disorder 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: